Please use this identifier to cite or link to this item:
Title: Mid-term outcomes in patients following transcatheter aortic valve implantation in the CoreValve Australia and New Zealand Study.
Epworth Authors: Walton, Anthony
Other Authors: Meredith, Ian
Walters, Darren
Pasupati, Sanjeevan
Muller, David
Worthley, Stephen
Yong, Gerald
Whitbourn, Robert
Duffy, Stephen
Ormiston, John
Keywords: Epworth Healthcare, Melbourne, Australia
Heart Surgery
Cardiac Services
Aortic Stenosis
Transcatheter Aortic Valve Implantation
Self-expanding Transcatheter Heart Valve
Medtronic CoreValve
Issue Date: Mar-2015
Publisher: Elsevier
Citation: Heart Lung Circ. 2015 Mar;24(3):281-90
Abstract: Although numerous studies have reported the safety and effectiveness of transcatheter aortic valve implantation (TAVI), integration of this therapy into standard of care varies widely by region. We evaluated mid-term follow-up in 540 patients with severe symptomatic AS at high risk of surgical AV replacement, enrolled in the ongoing Medtronic CoreValve Australia-New Zealand Study.
DOI: 10.1016/j.hlc.2014.09.023.
PubMed URL:
ISSN: 1443-9506
Journal Title: Heart, Lung & Circulation
Type: Journal Article
Affiliated Organisations: MonashHeart and Monash University, Melbourne, Australia
Alfred Hospital, Melbourne, Australia
Prince Charles Hospital, Brisbane, Australia
Waikato Hospital, Hamilton, New Zealand
St. Vincent's Sydney, Sydney, Australia
Royal Adelaide Hospital, Adelaide, Australia
Royal Perth Hospital, Perth, Australia
St. Vincent's Hospital, Melbourne, Australia
Mercy Hospital, Auckland, New Zealand
Type of Clinical Study or Trial: Case Control Studies
Appears in Collections:Cardiac Sciences

Files in This Item:
There are no files associated with this item.

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.